Pseudocarcinomatous Hyperplasia Masquerading as a Well-Differentiated Squamous Cell Carcinoma Associated With Primary Cutaneous Anaplastic Large-Cell Lymphoma

Am J Dermatopathol. 2022 Dec 1;44(12):952-954. doi: 10.1097/DAD.0000000000002319. Epub 2022 Sep 27.

Abstract

Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis associated with CD30 + lymphoproliferative disorders. In this article, we report the case of a 42-year-old man who presented with a 10-year history of a solitary erythematous patch on the right thigh that progressed to an ulcerated, crusted plaque. Histologic examination revealed an infiltrate of atypical CD30 + lymphocytes consistent with primary cutaneous anaplastic large-cell lymphoma with overlying well differentiated keratinocyte hyperplasia akin to a well-differentiated invasive squamous cell carcinoma. This case demonstrates the phenomenon of pseudocarcinomatous hyperplasia mimicking features of invasive squamous cell carcinoma. It highlights the necessity of careful clinical correlation when diagnosing squamous cell carcinomas in younger patients on non-sun-exposed areas and the exclusion of accompanying known causes of pseudocarcinomatous hyperplasia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma, Squamous Cell* / pathology
  • Humans
  • Hyperplasia
  • Ki-1 Antigen
  • Lymphoma, Large-Cell, Anaplastic* / pathology
  • Male
  • Skin Diseases* / complications
  • Skin Neoplasms* / pathology

Substances

  • Ki-1 Antigen